Cited by 143Liver Disease and TransplantationDrug-Induced Hepatotoxicity and ProtectionAcute Kidney Injury Research

The Natural History of Severe Acute Liver Injury

Open access
Koch, David G, Speiser, J L, Durkalski, V, Fontana, R J, Davern, T, McGuire, B, Stravitz, R T, Larson, A M +24 more·2017·American Journal of Gastroenterology

Abstract

OBJECTIVES: Acute liver failure (ALF) is classically defined by coagulopathy and hepatic encephalopathy (HE); however, acute liver injury (ALI), i.e., severe acute hepatocyte necrosis without HE, has not been carefully defined nor studied. Our aim is to describe the clinical course of specifically defined ALI, including the risk and clinical predictors of poor outcomes, namely progression to ALF, the need for liver transplantation (LT) and death. METHODS: 386 subjects prospectively enrolled in the Acute Liver Failure Study Group registry between 1 September 2008 through 25 October 2013, met criteria for ALI: International Normalized Ratio (INR)≥2.0 and alanine aminotransferase (ALT)≥10 × elevated (irrespective of bilirubin level) for acetaminophen (N-acetyl-p-aminophenol, APAP) ALI, or INR≥2.0, ALT≥10x elevated, and bilirubin≥3.0 mg/dl for non-APAP ALI, both groups without any discernible HE. Subjects who progressed to poor outcomes (ALF, death, LT) were compared, by univariate analysis, with those who recovered. A model to predict poor outcome was developed using the random forest (RF) procedure. RESULTS: Progression to a poor outcome occurred in 90/386 (23%), primarily in non-APAP (71/179, 40%) vs. only 14/194 (7.2%) in APAP patients comprising 52% of all cases (13 cases did not have an etiology assigned; 5 of whom had a poor outcome). Of 82 variables entered into the RF procedure: etiology, bilirubin, INR, APAP level and duration of jaundice were the most predictive of progression to ALF, LT, or death. CONCLUSIONS: A majority of ALI cases are due to APAP, 93% of whom will improve rapidly and fully recover, while non-APAP patients have a far greater risk of poor outcome and should be targeted for early referral to a liver transplant center.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ajg.2017.98

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Koch, D. G., Speiser, J. L., Durkalski, V, Fontana, R. J., Davern, T., McGuire, B., Stravitz, R. T., Larson, A. M., Liou, I., Fix, O., Schilsky, M. L., McCashland, T., Hay, J. E., Murray, N., Shaikh, O. S., Ganger, D., Zaman, A., Han, S. B., Chung, R. T., Brown, R. S., Munoz, S., Reddy, K. R., Rossaro, L., Satyanarayana, R., Hanje, A. J., Olson, J., Subramanian, R. M., Karvellas, C., Hameed, B., Sherker, A. H., Lee, W. M., & Reuben, A.
Affiliations
  • Medical University of South Carolina (US)
  • University of Michigan (US)
  • California Pacific Medical Center (US)
  • University of Alabama at Birmingham (US)
  • Virginia Commonwealth University (US)
  • University of Washington (US)
  • Swedish Medical Center (US)
  • Yale University (US)
  • University of Nebraska Medical Center (US)
  • Mayo Clinic (US)
  • Baylor University Medical Center (US)
  • University of Pittsburgh (US)
  • Northwestern University (US)
  • Oregon Health & Science University (US)
  • University of California, Los Angeles (US)
  • Massachusetts General Hospital (US)
  • Jefferson Einstein Philadelphia Hospital (US)
  • University of Pennsylvania (US)
  • University of California, Davis (US)
  • The Ohio State University (US)
  • University of Kansas Medical Center (US)
  • Emory University (US)
  • University of Alberta (CA)
  • University of California, San Francisco (US)
  • National Institute of Diabetes and Digestive and Kidney Diseases (US)
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Koch, David G
Venue
American Journal of Gastroenterology
Published
2017-09
Volume
112
Issue
9
Pages
1389-1396
ISSN
0002-9270 (ISSN-L)
OpenAlex
W2607713342
Cited by
143
References
31
Citations by year
2026: 9 · 2025: 13 · 2024: 21 · 2023: 13 · 2022: 19 · 2021: 15 · 2020: 20 · 2019: 17 · 2018: 10 · 2017: 6
FWCI
8.96
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058369, U01DK058369, P30DK043351)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
acute liver injury, acute liver failure, acetaminophen hepatotoxicity, liver necrosis, hepatic encephalopathy, liver transplantation, mortality, outcome prediction, random forest, bilirubin, international normalized ratio, natural history (disease)
MeSH terms
Adult, Alanine Transaminase, Data Interpretation, Statistical, Female, Hepatic Encephalopathy, Humans, Male, Middle Aged, Prognosis, Registries, Severity of Illness Index, United States, Adverse Drug Reaction Reporting Systems, International Normalized Ratio, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review